Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferonEdmonson, J H ; Kovach, J S ; Buckner, J C ; Kvols, L K ; Hahn, R GCancer research (Chicago, Ill.), 1988-11-15, Vol.48 (22), p.6584 [Peer Reviewed Journal]Full text available |
2 |
Material Type: Article
|
![]() |
Phase I study of recombinant leukocyte A interferon (IFN-α2A, Roferon-A) with doxorubicin in advanced malignant diseaseCREAGAN, E. T ; FRYTAK, S ; LONG, H. J ; KVOLS, L. KCancer, 1989, Vol.64 (5), p.1034-1037 [Peer Reviewed Journal]Full text available |
3 |
Material Type: Article
|
![]() |
Intralesional interferon alfa-2b treatment of condylomata acuminata previously resistant to podophyllum resin applicationBoot, J M ; Blog, F B ; Stolz, EGenitourinary Medicine, 1989-01, Vol.65 (1), p.50-53 [Peer Reviewed Journal]Full text available |
4 |
Material Type: Article
|
![]() |
Disordered interferon status in patients with urticaria and angioneurotic edema against a background of frequent ARVI: its correction with reaferonBelostotskaia, O I ; Grigorian, S S ; Poroshina, Iu A ; Ivanova, L A ; Gervazieva, V BVoprosy virusologiĭ, 1989-03, Vol.34 (2), p.176-180 [Peer Reviewed Journal]Full text available |
5 |
Material Type: Article
|
![]() |
Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in familiesA S Monto ; S A Schwartz ; J K AlbrechtAntimicrobial Agents and Chemotherapy, 1989-03-01, Vol.33 (3), p.387-390 [Peer Reviewed Journal]Full text available |
6 |
Material Type: Article
|
![]() |
Recent progress in the treatment of hematological malignancies. III. Acute leukemia--treatment with cytokinesUrushizaki, I ; Takaku, FNihon Naika Gakkai zasshi, 1989-06, Vol.78 (6), p.781-784Full text available |
7 |
Material Type: Article
|
![]() |
Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of responseChen, G ; Karayiannis, P ; McGarvey, M J ; Lever, A M ; McDonald, J A ; Scully, L J ; Kanatakis, S ; Thomas, H CGut, 1989-08, Vol.30 (8), p.1123-1128 [Peer Reviewed Journal]Full text available |
8 |
Material Type: Article
|
![]() |
Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence responseBrook, M G ; McDonald, J A ; Karayiannis, P ; Caruso, L ; Forster, G ; Harris, J R ; Thomas, H CGut, 1989-08, Vol.30 (8), p.1116-1122 [Peer Reviewed Journal]Full text available |
9 |
Material Type: Article
|
![]() |
Prediction or objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinomaFOSSA, S. D ; NESLAND, J. M ; MELVIK, J. E ; JACOBSEN, A. B ; MOE, BActa oncologica, 1990, Vol.29 (3), p.303-306 [Peer Reviewed Journal]Full text available |
10 |
Material Type: Article
|
![]() |
Recombinant Leukocyte Interferon Alpha-2A and Medroxyprogesterone in Advanced Renal Cell Carcinoma: A Randomized TrialSteineck, G ; Strander, H ; Carbin, B.-E ; Borgström, E ; Wallin, L ; Achtnich, U ; Arvidsson, A ; Söderlund, V ; Naslund, I ; Esposti, P.-L ; Norell, S. EActa oncologica, 1990, Vol.29 (2), p.155-162 [Peer Reviewed Journal]Full text available |